Adoption allows ICON to take full advantage of the Medidata "Data Experience," leveraging AI to unify data sources, standardize outputs, and reduce reconciliation efforts NEW YORK, March 20, ...
DUBLIN--(BUSINESS WIRE)-- ICON plc, (NASDAQ: ICLR) (“ICON”) today announced the completion of its acquisition of PRA Health Sciences. The combined company will retain the name ICON and will bring ...
LAUSANNE, Switzerland--(BUSINESS WIRE)--Saphetor SA today announce that it is partnering with world-leading healthcare intelligence and clinical research organisation ICON to develop an innovative ...
DUBLIN--(BUSINESS WIRE)--ICON plc, (NASDAQ: ICLR) a global provider of drug and device development and commercialisation services to pharmaceutical, biotechnology, medical device, and government ...
Irish contract research organisation ICON has secured a clinical pharmacology platform in the US by acquiring Healthcare Discoveries, an early-phase specialist based in San Antonio, Texas, for up to ...
Irish contract research organisation ICON is expanding its range of electronic data capture services through a technology partnership with US integrated data-management specialist Phase Forward. Irish ...
DUBLIN--(BUSINESS WIRE)-- ICON plc, (NASDAQ: ICLR) a leading global provider of drug and medical device development and commercialisation services, has won Best Contract Research Organisation – ...
The US Court of Appeals for the Seventh Circuit has joined its sister circuits in holding that the Supreme Court standard for awarding attorney’s fees in patent cases, set forth in Octane Fitness, was ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback